<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>PRASCION RA CREAM WITH SUNSCREENS- sulfacetamide sodium and sulfur cream </strong><br>Prasco Laboratories<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1>Prascion RA with Sunscreens Cream
sodium sulfacetamide 10% and sulfur 5%</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Each gram of PRASCION RA Cream With Sunscreens contains 100 mg of sodium sulfacetamide and 50 mg of sulfur in a cream containing avobenzone, benzyl alcohol, C12-15 alkyl benzoate, cetostearyl alcohol, dimethicone, edetate disodium, emulsifying wax, monobasic sodium phosphate, octinoxate, propylene glycol, purified water, sodium thiosulfate, steareth-2, steareth-21.</p>
<p>Sodium sulfacetamide is a sulfonamide with antibacterial activity while sulfur acts as a keratolytic agent. Chemically, sodium sulfacetamide is N-[(4-aminophenyl) sulfonyl]-acetamide, monosodium salt, monohydrate. The structural formula is:</p>
<p><img alt="Image of chemical structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=49052371-e1d6-4665-b82e-442bdf4b177d&amp;name=sodium%20sulfacetamide.jpg"></p>
<p></p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">The most widely accepted mechanism of action of sulfonamides is the Woods-Fildes theory which is based on the fact that sulfonamides act as competitive antagonists to para-aminobenzoic acid (PABA), an essential component for bacterial growth. While absorption through intact skin has not been determined, sodium sulfacetamide is readily absorbed from the gastrointestinal tract when taken orally and excreted in the urine, largely unchanged. The biological half-life has variously been reported as 7 to 12.8 hours.</p>
<p>The exact mode of action of sulfur in the treatment of <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span> in unknown, but it has been reported that it inhibits the growth of <span class="Italics"><span class="Italics">Propionibacterium <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acnes</span></span></span> and the formation of free fatty acids.<br></p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">PRASCION RA Cream With Sunscreens is indicated in the topical control of <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne vulgaris</span>, <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span> <span class="product-label-link" type="condition" conceptid="136773" conceptname="Rosacea">rosacea</span> and <span class="product-label-link" type="condition" conceptid="137053" conceptname="Seborrheic dermatitis">seborrheic dermatitis</span>.<br></p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">PRASCION RA Cream With Sunscreens is contraindicated for use by
patients having known <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to sulfonamides, sulfur or any
other component of this preparation. This drug is not to be used by
patients with kidney disease.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-5"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">Although rare, sensitivity to sodium sulfacetamide may occur. Therefore, caution and careful supervision should be observed when prescribing this drug for patients who may be prone to <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to topical sulfonamides. Systemic toxic reactions such as <span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">agranulocytosis</span>, <span class="product-label-link" type="condition" conceptid="435503" conceptname="Hemolytic anemia">acute hemolytic anemia</span>, <span class="product-label-link" type="condition" conceptid="4047773" conceptname="Purpura">purpura</span> hemorrhagica, <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">drug fever</span>, <span class="product-label-link" type="condition" conceptid="137977" conceptname="Jaundice">jaundice</span>, and <span class="product-label-link" type="condition" conceptid="134438" conceptname="Contact dermatitis">contact dermatitis</span> indicate <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to sulfonamides. Particular caution should be employed if areas of denuded or abraded skin are involved.<br></p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-6"></a><p></p>
<h1>PRECAUTIONS</h1>
<p class="First">Enter section text here</p>
<div class="Section" data-sectionCode="34072-9">
<a name="section-6.1"></a><p></p>
<h2>General</h2>
<p class="First">If irritation develops, use of the product should be discontinued and appropriate therapy instituted. For external use only. Keep away from eyes. Patients should be carefully observed for possible local irritation or sensitization during long-term therapy. The object of this therapy is to achieve <span class="product-label-link" type="condition" conceptid="135029" conceptname="Peeling of skin">desquamation</span> without irritation, but sodium sulfacetamide and sulfur can cause reddening and scaling of epidermis. These side effects are not unusual in the treatment of <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne vulgaris</span>, but patients should be cautioned about the possibility. Keep out of reach of children.<br></p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="section-6.2"></a><p></p>
<h2>Carcinogenesis, Mutagenesis and Impairment of Fertility</h2>
<p class="First">Long-term studies in animals have not been performed to evaluate carcinogenic potential.<br></p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-6.3"></a><p></p>
<h2>Pregnancy</h2>
<p class="First">Category C. Animal reproduction studies have not been conducted with PRASCION RA Cream with Sunscreens. It is also not known whether this drug can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. It should be given to a pregnant woman only if clearly needed.<br></p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="section-6.4"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">It is not known whether sodium sulfacetamide is excreted in human milk following topical use of PRASCION RA Cream With Sunscreens. However, small amounts of orally administered sulfonamides have been reported to be eliminated in human milk. In view of this and because many drugs are excreted in human milk, caution should be exercised when this drug is administered to a nursing woman.<br></p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="section-6.5"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">Safety and effectiveness in children under the age of 12 have not been established.<br></p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">Although rare, sodium sulfacetamide may cause local irriation.<br></p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-8"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">Apply a thin film of PRASCION RA Cream With Sunscreens to affected areas 1 to 3 times daily.<br></p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-9"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">45 g tubes (NDC 66993-925-45)<br></p>
</div>
<div class="Section" data-sectionCode="44425-7">
<a name="section-10"></a><p></p>
<p class="First">Store at controlled room temperature 15<span>°</span>-30<span>°</span>C (59<span>°</span>-86<span>°</span>F).</p>
<p>U.S. Patent No. 7,022,332    Patent Pending</p>
<p></p>
<p><img alt="Prasco Logo" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=49052371-e1d6-4665-b82e-442bdf4b177d&amp;name=Prasco_BkLogo%20Converted.jpg"></p>
<p>Manufactured for: <span class="Bold">Prasco Laboratories</span>, Mason, OH 45040  USA</p>
<p>Manufactured by: <span class="Bold">Stiefel Laboratories, Inc.</span>, Coral Gables, FL 33134</p>
<p>Iss. 01/09</p>
<p>302652<br></p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-11"></a><p></p>
<p class="First"><img alt="Prascion RA Cream Front Panel" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=49052371-e1d6-4665-b82e-442bdf4b177d&amp;name=Prascion%20RA%20Cream%20Front%20Panel.jpg"></p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>PRASCION RA CREAM 		
					WITH SUNSCREENS</strong><br><span class="contentTableReg">sodium sulfacetamide and sulfur cream</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:66993-925</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>Sulfacetamide Sodium</strong> (Sulfacetamide ) </td>
<td class="formItem">Sulfacetamide Sodium</td>
<td class="formItem">100 mg  in 45 g</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>Sulfur</strong> (Sulfur) </td>
<td class="formItem">Sulfur</td>
<td class="formItem">50 mg  in 45 g</td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:66993-925-45</td>
<td class="formItem">45 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">unapproved other</td>
<td class="formItem"></td>
<td class="formItem">06/30/2009</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Prasco Laboratories
							(065969375)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Stiefel Laboratories, Inc.</td>
<td class="formItem"></td>
<td class="formItem">002063378</td>
<td class="formItem">manufacture</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 8/2009<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>ae6dc7cd-0e01-4ef8-b172-cd88e7238f6f</div>
<div>Set id: 49052371-e1d6-4665-b82e-442bdf4b177d</div>
<div>Version: 2</div>
<div>Effective Time: 20090831</div>
</div>
</div> <div class="DistributorName">Prasco Laboratories</div></p>
</body></html>
